1. N. Ueberschaar, Dr. H. -M. Dahse, T. Bretschneider, Prof. Dr. C
N. Ueberschaar, Dr. H.-M. Dahse, T. Bretschneider, Prof. Dr. C. Hertweck
Leibniz Institute for Natural Product Research and Infection Biology, HKI
Beutenbergstr. 11a, Jena (Germany)
Prof. Dr. C. Hertweck
Friedrich Schiller University, Jena (Germany)

2. Introduction
Cancer
・ The leading cause of death.
(In 2007, cancer caused about 13% of all human deaths worldwide (7.9 million).)
・ Cancers are caused by a series of mutations.
→ Lacking of life span and rapidly growing of cells.
The most effective chemotherapeutics either interfere with the tumor cell cycle or bind to DNA and cause apoptosis through various downstream processes
Inhibiting cancer cell growth

3. DNA intercalators as medicine
Natural products represent the prime source of medicines.
a) J. Portugal, Curr. Med. Chem. 2003, 3, 411 – 420; b) M. Uramoto, T. Kusano, T. Nishio, K. Isono, K. Shishido, T. Ando, Febs Lett. 1983, 153, 325 – 328.
Chartarin
Chartarin
Chartreusin (1)
Elsamicin (2)
Figure 1. Structures of DNA intercalators and model of DNA binding.
a) Structures of the antitumor agents chartreusin (1) and elsamicin (2) sharing the chartarin aglycone (highlighted in blue).
The chartarin aglycone is capable of intercalating into DNA.
→ Inhibit RNA synthesis and cause DNA cutting.
×They lack selectivity against tumor cells and thus damage healthy tissue.

4. Photodynamic therapy This study
Light (UV)-induced release of cytotoxic agents
Activated-Drug
(Toxicity) UV
Doxorubicin Prodrug
(Lack toxicity)
×Short-wave (UV) may induce secondary cancers.
First successful tailoring of the chartarin analogue, which forms covalent links to DNA upon mild photoactivation with visible light and which has a markedly higher antitumoral potency than the parent compound.
This study

5. Design of new chartarin analogue 13
Canonical B-DNA b)
Chartreusin (1)
-GCGTATGATGCG-
Vinyl group c)
Thymine
[2+2] adduction OR 13 13
Figure 1. b) Model of vinylchartreusin binding to DNA. View of the major groove shows proximity of the aglycone vinyl residue to thymine. c) Distances of the thymine and vinyl carbon atoms measured in the model.
Vinyl-substituted chartarin aglycone is capable of forming [2+2] photo adducts in analogy to the gilvocarcin V family of angucyclic polyketide glycosides, which are efficiently activated in the near UVA spectrum (398 nm).

6. Evaluation of antiproliferative effects and induction of apoptosisb)
Chartreusin (1)
Vinyl-chartreusin (13)
HUVEC
K-562
HeLa
Figure 3. Evaluation of antiproliferative effects and induction of apoptosis.
a) GI50 (HUVEC, K-562) and CC50 (HeLa) values for chartreusin and its vinyl-substituted analogue. GI50=concentration required to cause 50% reduction in proliferation; CC50=cytostatic concentration required to reduce cell growth by 50%. b) Overlay of absorption spectrum of 13 in presence of DNA and emission spectrum of the blue LED light source. c) Image of the LED light source and a vial containing chartreusin showing its fluorescence.
Compared to chartreusin 1, 13 exhibits lower activity against cell lines.

7. Light-dependent antiproliferative effect on human colon adenocarcinoma cell line HT-29
Corresponding growth-inhibition values
Dose–response curve
Chartreusin (1)
Vinyl-chartreusin (13)
GI uM
GI uM
Figure 3. Evaluation of antiproliferative effects and induction of apoptosis.
d) Light-dependent antiproliferative effect on human colon adenocarcinoma cell line HT-29. Dose–response curve of 13 with and without light. e) Corresponding growth-inhibition values with and without light
・　The activity of 13 which is irradiated with the LED proved to be 12-fold higher than
without light .
・　In contrast, the activity of native chartreusin (1) was not affected by treatment with light.

8. Microscope images of the corresponding HT-29 cells
Figure 3. Evaluation of antiproliferative effects and induction of apoptosis.
f) Time-resolved effect of the inhibition of proliferation by vinylchartreusin (13) on HT-29 cells at a constant concentration (c=1.25 mgmL1). g) Microscope images of the corresponding HT-29 cells show chromatin condensation (black/white arrowhead) and cell blebbing (black arrowhead) indicative of apoptosis.
Cell blebbing, a characteristic sign of apoptosis, was observed after irradiation.

9. Light-induced DNA adduct formation
Electrophoretic mobility assay (EMSA)
Labeled DNA fragment
1.5 kb DNA fragment
DNA
53mg
53mg
53mg
53mg
0 mg
53mg
53mg
Subst. no no 1 1 13 13 13
405 nm
(30 sec)
405 nm
(30 sec)
405 nm
(30 sec)
Light no no no no
Figure 4. a) Agarose gel of 1.5 kb DNA fragment. Lanes 1,2: DNA samples without supplement; lanes 3,4: DNA incubated with chartreusin (1); lane 5: 13 without DNA; lanes 6,7: DNA incubated with 13; lanes 2, 4,7: samples irradiated with blue light (l=405 nm).
A clear band shift to a higher molecular mass was observed only when blue light was irradiated in the presence of 13.
(+ HPLC and MS analysis show the adduct formation. )
These results strongly suggests that light-induced DNA adduact formation was occured.

10. In summary
・The authors have developed a new photoactivatable chartreusin analogue.
・The novel chartreusin analogue can be activated by visible light, thus
minimizing UV-induced mutations.
・This study not only highlights the power of merging chemical and biochemical methods to generate complex, natural-product-derived antitumor agents,
but also reveals a lead that holds promise for curing skin cancers and tumors that are accessible with light probes.

11. Synthesis of 13 a–h) Synthesis of vinylchartarin (12).
a) Methoxymethyl chloride (MOM-Cl), diisopropylethylamine, CH2Cl2, 65%;
b) tBuLi, N,N,N’,N’-tetramethylethylenediamine, THF, DMF, 71%; c) trimethylsilyl cyanide, KCN, [18]crown-6, THF; d) AcOH, 60% (2 steps);
e) vinylboronic acid pinacol ester, [Pd(PPh3)4], dioxane water, 92% f) tBuOLi, THF; 71%; g) BBr3, CH2Cl2, 100%; h) [Pd(dppp)Cl2] (dppp=l,3-bis(diphenylphosphanyl)
propane), LiCl, nBu3Sn-vinyl, DMF, 20%;
i) biotransformation, 100% turnover rate, 31% yield of isolated 13.
PKS : Type II polyketide synthase
Scheme 1. Mutasynthesis of a chartreusin analogue.